Akèy › Anplwayè › Dana-Farber Cancer Institute › Instructor (Physician / Scientist)
Instructor (Physician / Scientist) nan Dana-Farber Cancer Institute: Salè H-1B
8 aplikasyon kondisyon travay pou tit travay Instructor (Physician / Scientist) nan Dana-Farber Cancer Institute. Salè baz medyàn ofri $209,000; mwatye mitan $204,750–$214,899.
Demann (LCA)8
Salè medyan ofri$209,000
Mwatye salè yo$204,750–$214,899
10yèm–90yèm pousantaj$184,500–$242,500
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $208,000 |
| FY2024 | 2 | $186,600 |
| FY2025 | 1 | $295,000 |
| FY2026 | 4 | $209,000 |
Aplikasyon
| Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|
| $210,000–$290,000 Nivo I | Boston, MA | Mar 9, 2026 | Sep 1, 2026 | Certifye, apre retire |
| $195,000–$200,000 Nivo II | Boston, MA | Jan 22, 2026 | Jul 1, 2026 | Certifye |
| $220,000–$275,000 Nivo I | Boston, MA | Sep 30, 2025 | Jan 1, 2026 | Certifye |
| $295,000 Nivo I | Boston, MA | Sep 15, 2025 | Nov 6, 2025 | Certifye |
| $160,000 Nivo IV | Boston, MA | May 14, 2024 | Oct 31, 2024 | Certifye |
| $208,000 | Boston, MA | Jun 22, 2023 | Jul 1, 2023 | Certifye, apre retire |
| $213,199–$213,200 | Boston, MA | Jun 13, 2023 | Nov 30, 2023 | Certifye, apre retire |
| $208,000 | Boston, MA | Mar 7, 2023 | Sep 1, 2023 | Certifye, apre retire |
Lòt travay nan Dana-Farber Cancer Institute
- Research Fellow$72,000
- Clinical Fellow$95,000
- Instructor (Scientist)$83,700
- Statistician$94,169
- Research Technician$50,000
- Scientist II$101,672
- Scientist$90,000
- Computational Biologist$81,272
- Sr. Research Technician$55,028
- Scientist I$89,685
- Advanced Clinical Fellow$104,500
- Instructor$92,754
- Genetic Counselor$90,000
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).